Objectives:

1. Conceptualize the description of immune dysregulation.

2. Understand the steps in identifying functionally relevant mutations in CTLA-4 and LRBA deficiency syndromes.

3. Learn about immune modulatory treatments targeting the checkpoint regulators and the consequences of treatment.

 

Session date: 
Thursday, March 15, 2018 - 12:00pm to 1:00pm
Location: 
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.